COHEN JOSHUA B (Co-Chief Executive Officer) sold 0.9% of their position (29.28K shares) of AMYLYX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $424.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001193125-26-091442
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
-29.28K
Net shares
Net seller
$424.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
29.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−29.28K
Price / share
$14.48
Trade value
$424.12K
% of position
0.9%
3/2/2026
3.36M→3.33M
Total
Net shares
−29.28K
Net value
-$424.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −29.28K | $14.48 | $424.12K | 0.9% | 3.36M | 3.33M |
| Total | −29.28K | -$424.12K | ||||||
Derivative Transactions0
No derivative transactions reported